Issue 8, 2017

In situ synthesis of Prussian blue nanoparticles within a biocompatible reverse micellar system for in vivo Cs+ uptake

Abstract

A new highly stable Prussian blue reverse micellar system comprising ultra-small Prussian blue nanoparticles in Aonys® (Peceol™, β-sitosterol, lecithin, ethanol and water) acts as an in vivo Cs+ uptake agent presenting higher efficiency compared to commercially available Prussian blue treatment with a significant dose effect.

Graphical abstract: In situ synthesis of Prussian blue nanoparticles within a biocompatible reverse micellar system for in vivo Cs+ uptake

Supplementary files

Article information

Article type
Letter
Submitted
02 Dec 2016
Accepted
03 Mar 2017
First published
15 Mar 2017

New J. Chem., 2017,41, 2887-2890

In situ synthesis of Prussian blue nanoparticles within a biocompatible reverse micellar system for in vivo Cs+ uptake

C. Lavaud, M. Kajdan, E. Compte, J. Maurel, J. Lai Kee Him, P. Bron, E. Oliviero, J. Long, J. Larionova and Y. Guari, New J. Chem., 2017, 41, 2887 DOI: 10.1039/C6NJ03770D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements